Effects of Treatments on Atopic Dermatitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 18, 2012

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions
EczemaDermatitisSkin Diseases, GeneticDermatitis, AtopicSkin Diseases
Interventions
DRUG

Trimethoprim/sulfamethoxazole (TMP/SMZ)

800/160 orally every 12 hours for 14 days

DRUG

Cephalexin

500 mg orally every 8 hours for 14 days

DRUG

Doxycycline

20 mg orally every 12 hours for 56 days or 100 mg orally every 12 hours for 56 days

OTHER

Sodium hypochlorite

6 % dilute bleach

OTHER

Placebo capsules

Capsule orally every 8 hours daily for 14 days

OTHER

Placebo Sodium hypochlorite

Three times a week for 14 days

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH